| 000 | 01434 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513044026.0 | ||
| 264 | 0 | _c19950124 | |
| 008 | 199501s 0 0 eng d | ||
| 022 | _a0003-9985 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRysenga, E | |
| 245 | 0 | 0 |
_aPeripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease. _h[electronic resource] |
| 260 |
_bArchives of pathology & laboratory medicine _cJan 1995 |
||
| 300 |
_a88-91 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocytes _xpathology |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, T-Cell _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMechlorethamine _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xchemically induced |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 |
_aProcarbazine _xadministration & dosage |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aLinden, M D | |
| 700 | 1 | _aCarey, J L | |
| 700 | 1 | _aRoss, C W | |
| 700 | 1 | _aSchnitzer, B | |
| 700 | 1 | _aSawdyk, M | |
| 700 | 1 | _aMaeda, K | |
| 773 | 0 |
_tArchives of pathology & laboratory medicine _gvol. 119 _gno. 1 _gp. 88-91 |
|
| 999 |
_c7801919 _d7801919 |
||